Ipratropium Bromide (Nebuliser Solution)
Generic / Active Ingredient
What is Ipratropium Bromide (Nebuliser Solution) used for?
Severe bronchospasm
5 Ipratropium Bromide (Nebuliser Solution) brands in Bangladesh
Compare prices across every brand of Ipratropium Bromide (Nebuliser Solution) and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| G-Ipra | 250 mcg/ml | Nebuliser Solution | Gonoshasthaya Pharma Ltd. | ৳ 55.00 |
| Ipramid | 250 mcg/ml | Nebuliser Solution | Beximco Pharmaceuticals Ltd. | ৳ 130.00 |
| Ipratop | 250 mcg/ml | Nebuliser Solution | Incepta Pharmaceuticals Ltd. | ৳ 130.00 |
| Iprex | 250 mcg/ml | Nebuliser Solution | Square Pharmaceuticals Ltd. | ৳ 130.88 |
| Rinase | 250 mcg/ml | Nebuliser Solution | ACI Limited | ৳ 130.39 |
Indication DetailsView
Ipratropium Nebuliser Solution is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Therapeutic ClassView
Anticholinergic bronchodilators
PharmacologyView
Ipratropium Bromide is a quaternary ammonium compound with anticholinergic properties. It appears to inhibit vagal reflexes by antagonising the action of acetylcholine (the transmitter agent released from the vagus nerve). Anticholinergics prevent the increase in intracellular concentration of cyclic guanosine monophosphate (cyclic GMP) caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle.
DosageView
Children over 3 years: The usual dose is 0.4-2.0 ml Ipratropium Bromide Solution (100-500 micrograms) up to three times daily.
Adults (including elderly and adolescents) over 12 years of age: The usual dose is 0.4-2.0 ml Ipratropium Bromide Solution (100-500 micrograms) up to four times daily.
Adults (including elderly and adolescents) over 12 years of age: The usual dose is 0.4-2.0 ml Ipratropium Bromide Solution (100-500 micrograms) up to four times daily.
Side EffectsView
Allergic-type reactions such as skin rash, angio-oedema of the tongue, lips and face, urticaria (including giant urticaria), laryngospasm and anaphylactic reactions have been reported, with positive rechallenge in some cases.
ContraindicationsView
Ipratropium Bromide solution should not be taken by patients with known hypersensitivity to atropine or its derivatives or to any other component of the product.
PrecautionsView
Ipratropium Bromide should be used with caution in patients predisposed to narrow-angle glaucoma, or with prostatic hyperplasia or bladder-neck obstruction.
Pregnancy & LactationView
The safety of Ipratropium Bromide during human pregnancy has not been established. The benefits of using Ipratropium Bromide during a confirmed or suspected pregnancy must be weighed against possible hazards to the unborn child. It is not known whether Ipratropium Bromide is excreted into breast milk.
Storage ConditionsView
Should be stored in cool and dry place